Skip to main content
medichelpline
Back to Clinical Feed
Try:
STATResearch Highlights

STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more

16 Jun 20264 min read0 views

GIST

Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us.

Moreover, the official mascots succeed in spotting various varmints — foxes and possums, to be specific, but thankfully, no vultures. As for us, we are heating our spiffy new replacement kettle for another cuppa stimulation.

Our choice today is old-fashioned green teas. And here is a helpful tip — a teaspoon of honey enhances the flavors splendidly.

Of course, you are invited to join us. For the full experience, we are now hawking replicas —  take a look .

Meanwhile, here are a few items of interest. As always, do keep in touch.

We appreciate feedback, criticism, and tips. … Weight loss drugs will be available to adults 65 and older in Medicare for the first time next month, thanks to a government program that is supposed to be temporary — but it may be difficult to end, STAT explains.

Clinical Editorial

Summary

STAT News published a clinical update in Research Highlights on 16 Jun 2026.

The item focuses on STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more.

Review the original article for the full source wording and details.

Source Reference

Read the full original publication from the source journal or publisher link below.